Other studies include CEDAR-HCM, a clinical trial of aficamten in a pediatric population with obstructive HCM. Cytokinetics, Incorporated Price, Consensus and EPS Surprise Cytokinetics, Incorporated price-consensus-eps-surprise-chart|Cytokinetics, Incorporated Quote CYTK’s Other Pipeline Candidates Other ...